Clinical strategies for the treatment of neuroblastoma
- 31 December 1995
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (4) , 568-571
- https://doi.org/10.1016/0959-8049(95)00032-e
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Association between High Levels of Expression of the TRK Gene and Favorable Outcome in Human NeuroblastomaNew England Journal of Medicine, 1993
- Fluorescence in situ hybridization combined with immunohistochemistry for highly sensitive detection of chromosome 1 aberrations in neuroblastomaCytogenetic and Genome Research, 1993
- Clinical impact of chromosome I aberrations in neuroblastoma: A metaphase and interphase cytogenetic studyGenes, Chromosomes and Cancer, 1992
- Dose-intensive use of cyclophosphamide in ablation of neuroblastomaCancer, 1990
- Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen)British Journal of Cancer, 1990
- Risk Factors in Neuroblastoma of InfantsPublished by S. Karger AG ,1990
- Neuroblastomas treated at the four major child oncologic clinics in Denmark 1943–1980: An evaluation of 180 casesMedical and Pediatric Oncology, 1985
- Intensive chemotherapy for metastatic neuroblastoma: A southwest oncology group studyMedical and Pediatric Oncology, 1980
- Multiagent chemotherapy for children with metastatic neuroblastoma: A report from childrens cancer study groupMedical and Pediatric Oncology, 1979
- A proposed staging for children with neuroblastoma.Children's cancer study group ACancer, 1971